These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 27631872)
1. Botulinum toxin A and/or soft tissue fillers for facial rehabilitation. Wollina U; Goldman A Wien Med Wochenschr; 2017 Mar; 167(3-4):92-95. PubMed ID: 27631872 [TBL] [Abstract][Full Text] [Related]
2. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler. Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460 [TBL] [Abstract][Full Text] [Related]
3. [Body experience and self-esteem after minimally invasive skin rejuvenation : Study of female patients using botulinum toxin A and/or dermal fillers]. Scharschmidt D; Preiß S; Brähler E; Fischer T; Borkenhagen A Hautarzt; 2017 Dec; 68(12):959-967. PubMed ID: 29052749 [TBL] [Abstract][Full Text] [Related]
5. Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations. Sundaram H; Liew S; Signorini M; Vieira Braz A; Fagien S; Swift A; De Boulle KL; Raspaldo H; Trindade de Almeida AR; Monheit G; Plast Reconstr Surg; 2016 May; 137(5):1410-1423. PubMed ID: 27119917 [TBL] [Abstract][Full Text] [Related]
6. Topical skin therapies in subjects undergoing full facial rejuvenation. Dayan SH; Bacos JT; Ho TT; Gandhi ND; Gutierrez-Borst S; Kalbag A J Cosmet Dermatol; 2019 Jun; 18(3):798-805. PubMed ID: 31033162 [TBL] [Abstract][Full Text] [Related]
7. Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations. Carruthers JDA; Glogau RG; Blitzer A; Plast Reconstr Surg; 2008 May; 121(5 Suppl):5S-30S. PubMed ID: 18449026 [TBL] [Abstract][Full Text] [Related]
8. Nonsurgical periocular rejuvenation: advanced cosmetic uses of neuromodulators and fillers. Pao KY; Mancini R Curr Opin Ophthalmol; 2014 Sep; 25(5):461-9. PubMed ID: 24926573 [TBL] [Abstract][Full Text] [Related]
9. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation. Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044 [TBL] [Abstract][Full Text] [Related]
10. Injectable treatments for the aging face. Wise JB; Greco T Facial Plast Surg; 2006 May; 22(2):140-6. PubMed ID: 16847805 [TBL] [Abstract][Full Text] [Related]
11. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes. Carruthers J; Carruthers A; Monheit GD; Davis PG Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457 [TBL] [Abstract][Full Text] [Related]
12. Facial Contouring With Fillers, Neuromodulators, and Lipolysis to Achieve a Natural Look in Patients With Facial Fullness. Anand C J Drugs Dermatol; 2016 Dec; 15(12):1536-1542. PubMed ID: 28095576 [TBL] [Abstract][Full Text] [Related]
13. Oculofacial contour asymmetries: Management of combined treatment with hyalurostructure and botulinum toxin injections. Berros P; Tsirbas A; Garcia P; Farhi D; Bétis F; Galatoire O J Cosmet Laser Ther; 2012 Apr; 14(2):111-6. PubMed ID: 22373036 [TBL] [Abstract][Full Text] [Related]
14. Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper face. Maas CS Facial Plast Surg Clin North Am; 2006 Aug; 14(3):241-5. PubMed ID: 16908391 [No Abstract] [Full Text] [Related]